Literature DB >> 18187495

Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina.

Andrzej Surdacki1, Ewa Marewicz, Ewa Wieteska, Grzegorz Szastak, Tomasz Rakowski, Ewa Wieczorek-Surdacka, Dariusz Dudek, Juliusz Pryjma, Jacek S Dubiel.   

Abstract

BACKGROUND: Low blood counts of CD34/kinase-insert domain receptor double-positive cells (CD34(+)/KDR(+) cells)-a leukocytes subpopulation enriched for bone marrow-derived endothelial progenitor cells (EPC)- predict adverse outcomes in coronary artery disease (CAD). The dependence of EPC numbers on the glomerular filtration rate (GFR), another prognostic factor, has not been reported in CAD yet. Our aim was to assess CD34(+)/KDR(+) cell counts versus GFR in stable angina.
METHODS: We studied 102 stable angina men with severe angiographic CAD and normal left-ventricular systolic function. CD34(+)/KDR(+) cells were enumerated by flow cytometry.
RESULTS: With lowering GFR, CD34(+)/KDR(+) cell numbers (% of lymphocytes, median and interquartile range) decreased: 0.04 (0.03-0.06), 0.03 (0.02-0.05) and 0.02 (0.01-0.03)% for GFR >or=90, 60-89 and 30-59 ml/min/1.73 m(2), respectively (P < 0.001 for trend). CD34(+)/KDR(+) cell counts correlated with GFR (r = 0.25, P = 0.01), CAD extension score (r = -0.20, P = 0.04), soluble form of vascular cell adhesion molecule-1 (sVCAM-1) (r = -0.22, P = 0.03) and homocysteine (r = -0.20, P = 0.04) levels. A GFR <90 ml/min/1.73 m(2) was associated with insignificantly higher plasma erythropoietin concentrations (r = -0.22, P = 0.09 for trend) that correlated with haemoglobin levels (r = -0.33, P = 0.01, n = 59). The GFR-CD34(+)/KDR(+) cells relation was attenuated, yet maintained (beta = 0.19 +/- 0.09, P = 0.04) on adjustment for the remaining multivariate determinants of CD34(+)/KDR(+) cell numbers: sVCAM-1 (beta = -0.20 +/- 0.09, P = 0.03) and haemoglobin (beta = 0.18 +/- 0.09, P = 0.05).
CONCLUSIONS: Mild-to-moderate renal dysfunction accompanying stable angina is associated with CD34(+)/KDR(+) cell depletion, which partially depends on concomitant endothelial dysfunction and a tendency to anaemia (despite insignificantly higher erythropoietin) irrespective of an angiographic CAD extent. This may exacerbate an imbalance between endothelial injury and EPC-mediated repair, thus contributing to high cardiovascular risk in CAD coexisting with renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187495     DOI: 10.1093/ndt/gfm943

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

Review 1.  Endothelial activation and circulating markers of endothelial activation in kidney disease.

Authors:  Ton J Rabelink; Hetty C de Boer; Anton J van Zonneveld
Journal:  Nat Rev Nephrol       Date:  2010-05-25       Impact factor: 28.314

2.  Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.

Authors:  Chun Liang; Yusheng Ren; Hongbin Tan; Zhiqing He; Qijun Jiang; Jianxiang Wu; Yi Zhen; Min Fan; Zonggui Wu
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

Review 3.  Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology.

Authors:  Linda Yaker; Saïd Kamel; Jérôme Ausseil; Agnès Boullier
Journal:  Toxins (Basel)       Date:  2020-12-21       Impact factor: 4.546

4.  Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study.

Authors:  Andrzej Surdacki; Olga Kruszelnicka; Tomasz Rakowski; Aleksandra Jaźwińska-Kozuba; Jacek S Dubiel
Journal:  Cardiovasc Diabetol       Date:  2013       Impact factor: 9.951

5.  Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.

Authors:  Olga Kruszelnicka; Andrzej Surdacki; Alain Golay
Journal:  Cardiovasc Diabetol       Date:  2013-10-09       Impact factor: 9.951

6.  Effects of Atorvastatin Dose and Concomitant Use of Angiotensin-Converting Enzyme Inhibitors on Renal Function Changes over Time in Patients with Stable Coronary Artery Disease: A Prospective Observational Study.

Authors:  Ewa Wieczorek-Surdacka; Jolanta Świerszcz; Andrzej Surdacki
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

7.  Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency.

Authors:  Anurag Mehta; Ayman S Tahhan; Chang Liu; Devinder S Dhindsa; Aditi Nayak; Ananya Hooda; Kasra Moazzami; Shabatun J Islam; Steven C Rogers; Zakaria Almuwaqqat; Ali Mokhtari; Iraj Hesaroieh; Yi-An Ko; Edmund K Waller; Arshed A Quyyumi
Journal:  JACC Basic Transl Sci       Date:  2020-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.